Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+86.1%
5Y CAGR+36.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+86.1%/yr
vs -5.4%/yr prior
5Y CAGR
+36.0%/yr
Recent acceleration
Acceleration
+91.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $28.48M | +267.7% |
| 2024 | $7.74M | -32.4% |
| 2023 | $11.45M | +159.0% |
| 2022 | $4.42M | +15.8% |
| 2021 | $3.82M | -37.7% |
| 2020 | $6.13M | +17.0% |
| 2019 | $5.23M | -5.3% |
| 2018 | $5.53M | +53.3% |
| 2017 | $3.60M | -20.8% |
| 2016 | $4.55M | - |